3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
Condition: OsteopeniaInterventions: Drug: Menostar (Estradiol, BAY86-5435); Drug: RaloxifeneSponsor: BayerCompleted - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Estradiol | Evista | Men | Menopause | Orthopaedics | Osteoporosis | Research | Study | Women